CORTINOVIS, DIEGO LUIGI
CORTINOVIS, DIEGO LUIGI
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Single-agent chemotherapy with vinorelbine for pretreated or metastatic squamous cell carcinoma of the esophagus
2001 Bidoli, P; Stani, S; De Candis, D; Cortinovis, D; Parra, H; Bajetta, E
Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancer
2003 Bajetta, E; Stani, S; De Candis, D; Zaffaroni, N; Zilembo, N; Cortinovis, D; Aglione, S; Mariani, L; Formisano, B; Bidoli, P
Integrated therapeutic strategies for anaplastic thyroid carcinoma
2003 Buzzoni, R; Catena, L; Cortinovis, D; Dognini, G; Bajetta, E
Phase I study of escalating doses of oxaliplatin in combination with fixed dose gemcitabine in patients with non-small cell lung cancer
2004 Bidoli, P; Stani, S; Mariani, L; De Candis, D; Cortinovis, D; Aglione, S; Zilembo, N; Toffolatti, L; Formisano, B; Bajetta, E
Efficacy of treatment with irinotecan and oxaliplatin combination in FU-resistant metastatic colorectal cancer patients
2004 Bajetta, E; Beretta, E; Di Bartolomeo, M; Cortinovis, D; Ferrario, E; Dognini, G; Toffolatti, L; Buzzoni, R
Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma
2004 Bajetta, E; Di Bartolomeo, M; Mariani, L; Cassata, A; Artale, S; Frustaci, S; Pinotti, G; Bonetti, A; Carreca, I; Biasco, G; Bonaglia, L; Marini, G; Iannelli, A; Cortinovis, D; Ferrario, E; Beretta, E; Lambiase, A; Buzzoni, R
Raltitrexed plus oxaliplatin in the treatment of metastatic colorectal cancer
2005 Cortinovis, D; Bajetta, E; Di Bartolomeo, M; Dognini, G; Beretta, E; Ferrario, E; Ricotta, R; Buzzoni, R
Case report of synchronous multicentric osteosarcoma and review of the literature: the importance of autopsy for diagnosis
2005 Buzzoni, R; Della Torre, S; Cortinovis, D; Catena, L
Metastatic melanoma
2007 Bajetta, E; Canova, S; Cortinovis, D
Pulmonary carcinoid tumours: indolent but not benign
2007 De Dosso, S; Bajetta, E; Procopio, G; Cortinovis, D; Buzzoni, R; Catena, L; Platania, M; Verzoni, E
Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study
2007 Gridelli, C; Ferrara, C; Guerriero, C; Palazzo, S; Grasso, G; Pavese, I; Satta, F; Bajetta, E; Cortinovis, D; Barbieri, F; Gebbia, V; Grossi, F; Novello, S; Baldini, E; Gasparini, G; Latino, W; Durante, E; Giustini, L; Negrini, C
Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study
2007 Bidoli, P; Zilembo, N; Cortinovis, D; Mariani, L; Isa, L; Aitini, E; Cullurà, D; Pari, F; Nova, P; Mancin, M; Formisano, B; Bajetta, E
FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancer
2008 Cortinovis, D; Andriani, F; Livio, A; Fabbri, A; Perrone, F; Marcomini, B; Pilotti, S; Mariani, L; Bidoli, P; Bajetta, E; Roz, L; Sozzi, G
Oxaliplatin doublets in non-small cell lung cancer: A literature review
2008 Cortinovis, D; Bidoli, P; Zilembo, N; Fusi, A; Bajetta, E
Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials
2008 Ceresoli, G; Castagneto, B; Zucali, P; Favaretto, A; Mencoboni, M; Grossi, F; Cortinovis, D; Del Conte, G; Ceribelli, A; Bearz, A; Salamina, S; De Vincenzo, F; Cappuzzo, F; Marangolo, M; Torri, V; Santoro, A
Is irinotecan plus docetaxel useful as second-line therapy in advanced non-small cell lung cancer?
2008 Cortinovis, D; Bidoli, P; Cullurà, D; Lorusso, V; Ardizzoia, A; Amoroso, V; Bandera, M; Aitini, E; Fusi, A; Zilembo, N; Radula, D; Bajetta, E
Dorsal sural nerve conduction study in the assessment of oxaliplatin induced peripheral neuropathy
2010 Alberti, P; Frigeni, B; Cavaletti, G; Ferrarese, C; Ferrara, R; Piccirilli, C; Resta, G; De Ponti, A; Rotondi, A; Della Vecchia, A; Villa, P; Cortinovis, D; Longarini, L; Acquati, M; Bidoli, P
Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools
2010 Cavaletti, G; Frigeni, B; Lanzani, F; Mattavelli, L; Susani, E; Alberti, P; Cortinovis, D; Bidoli, P
Isotretinoin plus clindamycin seem highly effective against severe erlotinib-induced skin rash in advanced non-small cell lung cancer
2010 Bidoli, P; Cortinovis, D; Colombo, I; Crippa, A; Cicchiello, F; Villa, F; Cazzaniga, M; Altomare, G
Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating Epidermal Growth Factor Receptor mutation: Implications for clinical practice and open issues
2011 Gridelli, C; De Marinis, F; Di Maio, M; Cortinovis, D; Cappuzzo, F; Mok, T